RxDoctor Payments Data

Jeffrey Vander Kooi, MD

Psychiatry · Chesterfield, MONPI 1407881675

Payments from drug & device makers

$413in general payments, 2019–2025

Across 38 payments — averaging $10.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$232
  • Orexo US, Inc.$112
  • Supernus Pharmaceuticals, Inc.$58
  • Otsuka America Pharmaceutical, Inc.$11

What the payments were for

  • Food & beverage$413100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$413 in reported general payments places this provider in the 55th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri

Medicare billing

Part B allowed, 2024
$155,489
Medicare patients
140
Services billed
1,615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$101,255
RexultiBrexpiprazole13$18,001
Aripiprazole165$8,927
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl58$8,527
Quetiapine Fumarate194$8,440
Bupropion XlBupropion Hcl240$8,313
Duloxetine Hcl200$7,615
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine138$4,700
Gabapentin141$4,674
Lisdexamfetamine Dimesylate11$4,662
Atomoxetine Hcl31$4,281
Clomipramine Hcl17$4,220
Fluvoxamine Maleate56$4,117
CymbaltaDuloxetine Hcl12$3,722
Trazodone Hcl189$3,199

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$11$18,00113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 680 psychiatry providers in Missouri.

Other psychiatry in Chesterfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →